Erectile dysfunction is a very common sexual problem affecting 100 million people worldwide. It is often contributed by neurological disorders, cardiovascular diseases, diabetes, hormonal imbalance and obesity. The incidence of erectile dysfunction is also proportionate to ageing, along with being associated with certain risk factors such as usage of tobacco and alcohol, certain medications and medical treatment, injuries and psychological conditions.
This report contains market size and forecasts of Erectile Dysfunction Treatment Drugs in Global, including the following market information:
- Global Erectile Dysfunction Treatment Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Erectile Dysfunction Treatment Drugs market was valued at 4995.6 million in 2021 and is projected to reach US$ 7328.5 million by 2028, at a CAGR of 5.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Phosphodiesterase Type 5 Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Erectile Dysfunction Treatment Drugs include Pfizer Inc., Dong-A Pharmaceutical Co. Ltd, Vivus, Inc., Meda Pharmaceuticals, Bayer AG, Johnson & Johnson Services, Apricus Biosciences and Eli Lilly, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Erectile Dysfunction Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Erectile Dysfunction Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Erectile Dysfunction Treatment Drugs Market Segment Percentages, by Type, 2021 (%)
- Phosphodiesterase Type 5 Inhibitors
- Prostaglandin E1
Global Erectile Dysfunction Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Erectile Dysfunction Treatment Drugs Market Segment Percentages, by Application, 2021 (%)
Global Erectile Dysfunction Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Erectile Dysfunction Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Erectile Dysfunction Treatment Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Erectile Dysfunction Treatment Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer Inc.
- Dong-A Pharmaceutical Co. Ltd
- Vivus, Inc.
- Meda Pharmaceuticals
- Bayer AG
- Johnson & Johnson Services
- Apricus Biosciences
- Eli Lilly
